Work

Klotho-derived peptide 1 inhibits cellular senescence in the fibrotic kidney by restoring Klotho expression via posttranscriptional regulation

Year: 2023
Type: article
Abstract: Background: Klotho deficiency is a common feature of premature aging and chronic kidney disease (CKD).As such, restoring Klotho expression could be a logic strategy for protecting against various nephropathies.In this study, we demonstrate that KP1, a Klotho-derived peptide, inhibits cellular senescence by restoring endogenous Klotho expression.Methods: The effects of KP1 on cellular senescence and Klotho expression were assessed in mouse models of CKD.RNA-sequencing was employed to identify the microRNA involved in regulating Klotho by KP1.Gain-or loss-of-function approaches were used to assess the role of miR-223-3p and IncRNA-TUG1 in regulating Klotho and cellular senescence.Results: KP1 inhibited senescence markers p21, p16 and γ-H2AX in tubular epithelial cells of diseased kidneys, which was associated with its restoration of Klotho expression at the posttranscriptional level.Profiling of kidney microRNAs by RNA sequencing identified miR-223-3p that bound to Klotho mRNA and inhibited its protein expression.Overexpression of miR-223-3p inhibited Klotho and induced p21, p16 and γ-H2AX, which were negated by KP1.Conversely, inhibition of miR-223-3p restored Klotho expression, inhibited cellular senescence.Furthermore, miR-223-3p interacted with lncRNA-TUG1 and inhibited its expression.Knockdown of lncRNA-TUG1 increased miR-223-3p, aggravated Klotho loss and worsened cellular senescence, whereas KP1 mitigated all these changes.Conclusion: These studies demonstrate that KP1 inhibits cellular senescence and induces Klotho expression via posttranscriptional regulation mediated by miR-223-3p and lncRNA-TUG1.By restoring endogenous Klotho, KP1 elicits a broad spectrum of protective actions and could serve as a promising therapeutic agent for fibrotic kidney disorders.
Source: Theranostics
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,671
OpenAlex ID: W4389340229
FWCI: 11.53
Cites: 63
Cited by: 67
Related to: 10